Johnson & Johnson (J&J) has agreed to pay $966 million to settle lawsuits claiming that its talc-based baby powder caused cancer. The settlement marks another major chapter in the company’s long-running legal battle over allegations that its baby powder contained asbestos, a substance linked to ovarian cancer and mesothelioma.
What Happened
The pharmaceutical giant announced the settlement to resolve thousands of pending lawsuits across several U.S. states. While J&J continues to deny any wrongdoing, it stated that the payout aims to end ongoing litigation and bring relief to affected families.
The company said it will continue to defend its talc products’ safety, citing multiple scientific studies showing no link between talc and cancer. However, this latest agreement is part of J&J’s broader effort to move past years of legal battles and focus on its core healthcare business.
Background
Over the past decade, Johnson & Johnson has faced more than 60,000 lawsuits alleging that its talc products contained asbestos and caused cancer. The company has already spent billions of dollars on settlements and legal fees.
In 2020, J&J stopped selling its talc-based baby powder in the U.S. and Canada, switching to a cornstarch-based formula. The company announced in 2022 that it would discontinue talc-based powder worldwide by 2023.
Summary Table
| Particulars | Details |
|---|---|
| Company | Johnson & Johnson |
| Settlement Amount | $966 million |
| Issue | Baby powder linked to cancer (talc-asbestos lawsuits) |
| Number of Lawsuits | Over 60,000 filed |
| Product Involved | Talc-based Baby Powder |
| J&J’s Stance | Denies wrongdoing; claims products are safe |
| Previous Actions | Stopped U.S. sales in 2020; global stop by 2023 |
| Goal of Settlement | End ongoing litigation and provide closure |
Industry Impact
The settlement could encourage other companies facing product liability suits to seek early resolutions. It also highlights growing consumer awareness about product safety and corporate accountability.
Company Statement
J&J said in a statement:
“We continue to stand by the safety of our talc-based products. This settlement allows us to move forward and focus on improving global health.”
Key Takeaway
The $966 million settlement doesn’t mean Johnson & Johnson admits fault, but it signals the company’s intention to close one of the largest legal challenges in its history. Consumers worldwide are now more alert about product ingredients and long-term health risks.
